Successful Market Access of SaMD & MDSW: Decoding the Confusion in MedTech Software Development
- Avania
- Regulatory Affairs
Software as a medical device (SaMD) is an ever-evolving field, whether it’s the latest updates in risk classification or optimizing your use of the FDA Pre-Cert program for more iterative product development, it is important to know where you stand and what data you need to be successful. Read our white paper to “decode the confusion” in MedTech software development and keep your SaMD project on time and on budget.
Related Reading
Event / Global & Trade / Regulatory Affairs
Entering the Japanese Medical Device Market: Regulatory Pathways, Consultation Opportunities, and Practical Insights
September 1, 2026 |
7:00 PM – 8:30 PM ET
September 2, 2026 |
8:00 AM – 9:30 AM JST
Learn how to enter Japan’s medtech market with insights on regulatory pathways, consultation services, and practical insights for U.S. medtech companies.
Event / Regulatory Affairs
The Widening AI Gap: Why AI-First MedTech Companies Are Pulling Ahead
July 28, 2026
12:00 PM – 1:00 PM
Join Boston Consulting Group as they explore how medtech organizations are using AI to transform product development and accelerate innovation.
News / Government & Legislative Affairs / Regulatory Affairs
AdvaMed Welcomes Key Developments in MDUFA VI Process
July 8, 2026
WASHINGTON, D.C.—AdvaMed, the Medtech Association, today welcomed next steps in the Medical Device User Fee Amendments reauthorization process following clearance by the White House Office of Management and Budget of the draft MDUFA VI agreement.
News / Coverage & Payment / Diagnostics / Digital Health / Government & Legislative Affairs / Health Access / Regulatory Affairs
AdvaMed Statement on the Klomp Nomination
June 26, 2026
WASHINGTON—Scott Whitaker, president and CEO of AdvaMed, the largest trade association representing medtech innovators, posted his statement on LinkedIn regarding the nomination of Chris Klomp as deputy secretary of the Department of Health and Human Services.
Blog / Coverage & Payment / Digital Health / Government & Legislative Affairs / Health Access / Regulatory Affairs
Essential Tremor Treatment: A Sensible Solution, Possibly Driven Out of Reach
June 22, 2026
Millions of Americans have the neurological condition essential tremor. Often, that means their hand shakes so badly, they can’t hold a pen, fork, or glass of water. Every activity of daily living is compromised, day and night.
Resource / China / Global & Trade / Regulatory Affairs / Standards
China GMP and ISO 13485: A Side-by-Side Comparison
June 22, 2026
China GMP and ISO 13485: A Side-by-Side Comparison
Event / Regulatory Affairs
Accelerating Medtech Innovation Through AI-Enabled Product Development
June 24, 2026
12:00 PM – 1:00 PM
Join Kearney as they explore how medtech organizations are using AI to transform product development and accelerate innovation.
Event / Regulatory Affairs
Accelerating ASC Transition and Medtech Commercial Model Imperatives
July 21, 2026
11:00 AM – 12:00 PM
Explore ASC growth trends, buyer dynamics & go-to-market strategies for medtech manufacturers in this webinar with Alexander Group.